Browse the full record of transactions filed by Soteropoulos Paula, Director. Officer active across 1 company, notably uniQure N.V.. Aggregated, 3 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €9k. Activity tracked since 24 February 2022. The latest transaction was filed on 15 June 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
3 of 3 declarations
Paula Soteropoulos is a Director at uniQure N.V., a biopharmaceutical company specializing in gene therapy. In her role, she contributes to corporate governance and the strategic direction of the organization. uniQure is at the forefront of innovation in genetic treatments, and Soteropoulos's experience in the sector allows her to provide valuable insights to the board.